| (+)-CATECHIN | IC50=546-5,910 uM (cf indomethacin IC50=1 uM) | * |
| 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER | IC18=100 ug/ml | * |
| AIPHANOL | -- | * |
| AJOENE | -- | * |
| ALPHA-BOSWELLIC-ACID | -- | * |
| ANTHOCYANINS | IC47=125 ug/ml | * |
| APIGENIN | IC>65=1,000 uM | * |
| APIGENIN | IC50=<15 uM | * |
| APIGENIN | <40 uM | * |
| AR-TURMERONE | IC50=5.6 ug/ml | * |
| BAICALEIN | 100 ug/ml | * |
| BERBERASTINE | 100 ug/ml | * |
| BERBERINE | 100 ug/ml | * |
| BETA-CAROTENE | IC82=50 ug/ml | * |
| BETA-TURMERONE | IC50=1.6 ug/ml | * |
| BOSWELLIC-ACID | -- | * |
| CAFFEIC-ACID | IC32=100 uM | * |
| CINNAMALDEHYDE | IC50=245 uM | * |
| CINNAMIC-ACID-BORNYL-ESTER | IC19=100 ug/ml | * |
| CIRSILINEOL | IC>37=1,000 uM | * |
| CIRSIMARITIN | IC>50=1,000 uM | * |
| CURCUMIN | 10-20 uM | * |
| CYANIDIN-3-O-GLUCOSIDE | IC59=100 ug/ml | * |
| EICOSAPENTAENOIC-ACID | 1 uM | * |
| EMODIN | -- | * |
| EUGENOL | IC50=129 uM | * |
| EUGENOL | IC>97=1,000 uM | * |
| EVODIAMINE | 2.5 ug/ml | Kang, S. S., Kim, J. S., Son, K. H., Kim, H. P., Chang, H. W. 1999. Cyclooxygenase-2 Inhibitor from Evodia rutaecarpa. Nat. Prod. Sci., 5(2): 65-69. |
| EVODOL | 2.5 ug/ml | Kang, S. S., Kim, J. S., Son, K. H., Kim, H. P., Chang, H. W. 1999. Cyclooxygenase-2 Inhibitor from Evodia rutaecarpa. Nat. Prod. Sci., 5(2): 65-69. |
| FLAVOKAWAIN-B | IC16=100 ug/ml | * |
| HUMULONE | -- | Yamamoto, Wang, et al. 2000. Federation of European Biochemical Societies. (per e-mail with Tom Newmark) |
| ISOTHYMONIN | IC>37=1,000 uM | * |
| KAEMPFEROL | -- | * |
| LAURIC-ACID | IC20=100 | * |
| MELATONIN | -- | Newmark, T. M. and Schulick, P. 2000. Herbal Cox-2 Inhibition - Nature's Challenge to Arthritis, Cancer & Alzheimer's Disease. Hohm Press, Prescott AZ. |
| MYRICETIN-3-O-BETA-D-GLUCURONIDE | IC50=8 uM/ | Hiermann, A., Schramm, H. W., Laufer, S. 1998. Anti-Inflammatory Activity of Myricetin-3--O-beta-d-glucuronide and Related Compounds. Inflamm. Res., 47(11): 421-427. |
| OLEANOLIC-ACID | IC50=295 uM/ | * |
| OLEANOLIC-ACID | -- | Ringbom, T., Seguar, L., Noreen, Y., Perera, P., Bohlin, L. 1998. Ursolic Acid from Plantago major, a Selective Inhibitor of Cyclooxygenase-2 Catalyzed Prostaglandin Biosynthesis. J. Nat. Prod., 61(10): 1212-1215. |
| PARTHENOLIDE | -- | Newmark, T. M. and Schulick, P. 2000. Herbal Cox-2 Inhibition - Nature's Challenge to Arthritis, Cancer & Alzheimer's Disease. Hohm Press, Prescott AZ. |
| PINOSTROBIN | IC7=100 ug/ml | * |
| PTEROSTILBENE | IC50=84 uM | * |
| PUNICIC-ACID | -- | * |
| QUERCETIN | <40 uM | * |
| RESVERATROL | >2.5->22.5 uM | * |
| RESVERATROL | 30 uM/ | Subbaramaiah, K., Michaluart, P., Chung, W. J., Dannenberg, A. J. 1998. Resveratrol Inhibits the Expression of Cyclooxygenase-2 in Human Mammary and Oral Epithelial Cells. Pharm. Biol. Suppl., 36: 35-43. |
| RESVERATROL | 50 uM/ | * |
| ROSMARINIC-ACID | IC>58=1,000 uM | * |
| RUTAECARPINE | 2.5 ug/ml (strong activity) | Kang, S. S., Kim, J. S., Son, K. H., Kim, H. P., Chang, H. W. 1999. Cyclooxygenase-2 Inhibitor from Evodia rutaecarpa. Nat. Prod. Sci., 5(2): 65-69. |
| SALICYLIC-ACID | -- | Newmark, T. M. and Schulick, P. 2000. Herbal Cox-2 Inhibition - Nature's Challenge to Arthritis, Cancer & Alzheimer's Disease. Hohm Press, Prescott AZ. |
| TRANS-RESVERATROL | 20 uM/ | Jang, M., Pezzuto, J. M. 1999. Cancer Chemorpreventive Activity of Resveratrol. Drugs Exp. Clin. Res., 25(2/3): 65-77. |
| UROLITHIN-A | -- | * |
| URSOLIC-ACID | IC50=130 uM/ | * |